Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. (Q54420300)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dermatophagoides pteronyssinus

1 reference

based on heuristic

inferred from title

allergic asthma

1 reference

based on heuristic

inferred from title

author name string

Nhân Pham-Thi

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Pierre Scheinmann

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Riad Fadel

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Anne Combebias

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Claude Andre

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Pediatric Allergy & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

18

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

47-57

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

Indoor allergens and asthma: report of the Third International Workshop

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Noninjection routes for immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Mechanisms of immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Immune mechanisms of allergen-specific sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Stepping down inhaled corticosteroids in asthma: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Development of child-centered disease-specific questionnaires for living with asthma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Results of a home-based environmental intervention among urban children with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

A randomized controlled trial of mite allergen-impermeable bed covers in adult mite-sensitized asthmatics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Safety of sublingual immunotherapy in children with asthma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

The safety of sublingual-swallow immunotherapy: an analysis of published studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00475.X

21 January 2018

Identifiers

10.1111/J.1399-3038.2006.00475.X

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17295799

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54420300&oldid=1525135886"